Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

NCT00083005 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: docetaxel
DRUG: estramustine phosphate sodium
DRUG: thalidomide

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]